Clinical Trial

Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy

Name: Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy — clinical trial record (NCT07545967)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

To evaluate the safety and tolerability of re-irradiation combined with chidamide in patients with recurrent head and neck squamous cell carcinoma after radiotherapy.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-29

Trial Details

NCT Number	NCT07545967
Lead Sponsor	West China Hospital
Conditions	Head and Neck Squamous Cell Carcinoma HNSCC
Enrollment	6 participants
Start Date	2026-04-23
Primary Completion	2027-07-01 (estimated)
Study Completion	2027-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-28